Fortis Inc. (FTS)

Theseus Pharmaceuticals Analyst Ratings

• Total Analysts: 1
• Consensus Rating: Hold
• Price Target: $72.00
• Upside: +44.32%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Maurice Choy RBC Capital	RBC Capital	Hold Maintains $69 → $72	Hold	Maintains	$69 → $72	+44.32%	May 8, 2025
Andrew Kuske Credit Suisse	Credit Suisse	Hold Maintains $62 → $61	Hold	Maintains	$62 → $61	+21.27%	Aug 24, 2023
David Quezada Raymond James	Raymond James	Buy Maintains $65 → $62	Buy	Maintains	$65 → $62	+24.27%	Aug 3, 2023
Maurice Choy RBC Capital	RBC Capital	Hold Reiterates $65	Hold	Reiterates	$65	+30.29%	Mar 24, 2023
David Quezada Raymond James	Raymond James	Hold → Buy Upgrades $58	Hold → Buy	Upgrades	$58	+16.26%	Oct 19, 2022
Mike Doyle Edward Jones	Edward Jones	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jul 27, 2022
Robert Hope Scotiabank	Scotiabank	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Jan 7, 2022
Steve Fleishman Wolfe Research	Wolfe Research	Hold → Sell Downgrades n/a	Hold → Sell	Downgrades	n/a	n/a	Oct 19, 2021
Ross Fowler UBS	UBS	Strong Buy Maintains $59 → $62	Strong Buy	Maintains	$59 → $62	+24.27%	Jun 5, 2020
Neil Kalton Wells Fargo	Wells Fargo	Buy Maintains $59 → $64	Buy	Maintains	$59 → $64	+28.28%	Feb 14, 2020
Mark Jarvi CIBC	CIBC	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Jan 30, 2020
Neil Kalton Wells Fargo	Wells Fargo	Buy Reiterates $61 → $59	Buy	Reiterates	$61 → $59	+18.26%	Nov 22, 2019
Mark Jarvi CIBC	CIBC	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Aug 22, 2019
Linda Ezergailis TD Securities	TD Securities	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jan 29, 2019
Ross Fowler UBS	UBS	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	May 2, 2018
Richard Sunderland JP Morgan	JP Morgan	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Feb 27, 2017